A new drug created with artificial intelligence, rentosertib, has shown potential in slowing down ageing, according to findings from a Phase IIa clinical trial published in Nature Biotechnology. The trial results suggest that the drug may influence biological-age markers. This development could represent a breakthrough in anti-ageing treatments.
Related Articles
Don't miss out on breaking stories and in-depth articles.